- ￥403
- 百生跃(Bioleaper)
- 上海
- BR2010713
- 2025年07月09日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
1年
- 英文名：
Anti-IL-23a Reference Antibody (risankizumab)
- 库存：
999
- 供应商：
百生跃(Bioleaper)
- 规格：
50μg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tumor reactive monoclonal antibodies (mAb) have been developed and tested as anti-tumor therapy. Some mAb have shown efficacy and are now approved as clinical cancer therapy. The mechanism of action for the antitumor effect includes tumor
Antibody Production and Immunocytochemical Localization of Amino Acid Transporters
This chapter details the procedural and conceptual issues that underpin the localization of high-affinity amino acid transporters by immunocytochemistry, with particular reference to the mammalian nervous system. Defining a role
Standardized Sequence and Structure Analysis of Antibody Using IMGT
Standardized sequence and structure analysis of antibody using IMGT�, the international ImMunoGeneTics information system� (http://www.imgt.org), allows to bridge, for the first time, the gap between antibody sequences and three-dimensional
技术资料暂无技术资料 索取技术资料
